All News

ACR Best

ACR21 Best Abstracts - Day 4

Jack Cush, MD

On the last day of ACR21 Annual Meeting, the RheumNow faculty selected these 15 as their favorite reports.

Read Article
EULAR19.abstract.jpg (keep)

ACR21 – Day 3 Report

Jack Cush, MD

Hitting the home stretch, day 3 presentations were big! Here are a few of my favorites: secukinumab efficacy in juvenile PsA; VEXAS - predicting poor outcomes; and the FDA Safety Update session.

Read Article
rare

Risks associated with mortality in VEXAS

Md Yuzaiful Md Yusof, MRCP(UK), PhD

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it was first introduced at ACR20 last year. It got everyone’s thinking that they might have encountered one or two patients in their rheumatology lifetime who might have this condition.

Read Article
ACR Best

ACR21 Best Abstracts We Saw - Day 3 (Monday)

Jack Cush, MD

The third day of ACR 2021 took a big leap in online content.  Here is a compilation (with links) of presentations were the “ACRBest” as seen by our RheumNow faculty. 

Read Article
Cush ACR learning computer online

Day 2 Report from ACR21

Jack Cush, MD

This report highlights the VITAL trial; the ORAL Surveillance Study; and the Microbiome study of monozygotic psoriasis patients.

Read Article
An Exclusive Interview with Dr. Al Kim (#Wowkim): Dr. Kathryn Dao ( @KDAO2011 ) interviews Dr. Alfred Kim (aka #Wowkim) about the exciting work he's presenting at the #ACR21 annual meeting. https://t.co/34EZIz2OFG https://t.co/mhaUcIhTKu

Links:

Dr. John Cush RheumNow ( View Tweet)
🎉 To celebrate the start of #ACR21, I'm happy to share this slide about #autoantibodies in systemic #autoimmune diseases such as #lupus, sjogren, systemic sclerosis, myosotis...and their main targets 🎯 As you may guess this took me a few hours to assemble... https://t.co/fNmgfOFbiD
Laurent ARNAUD Lupusreference ( View Tweet)
@ACRheum This 👇👇👇idea from @nighat I moderated a panel of women leaders in a virtual world - one of the attendees is a trainee from a 3rd world country and had a hard time finding ways to get help/collaboration for research studies; she wanted to know what she could do #ACR21 https://t.co/4Jn8jYUXME
TheDaoIndex KDAO2011 ( View Tweet)
We are live! RheumNow Daily Recap - #ACR21 https://t.co/ILaj7CImXY via @YouTube

Links:

Dr. John Cush RheumNow ( View Tweet)

Looking forward to the #ACR21 roundup by Drs. Cush and Kavanaugh at 7pm EST tonight. Always entertaining and informative. A highlight of ACR for me. We met in person the last time in Atlanta #ACR19. It’s virtual & the link is at @RheumNow Hope to meet in person again #ACR22 🤞 https://t.co/pgAcBExL7G
Dr. Antoni Chan synovialjoints ( View Tweet)
More thoughts from @ashira_md's talk on Gaslighting/microaggressions from #ACR21 ... (Q 1/2) Providers: have you ever been told you are difficult and/or challenging?

Elizabeth Graef SituationRheum ( View Tweet)

Miss anything from Day 1? We are sharing the best #ACR21 abstracts from Day 1. https://t.co/YZ3jwW0Abu https://t.co/gvWCrIbWuG

Links:

Dr. John Cush RheumNow ( View Tweet)
Fun things at #ACR21. Abs1186 #Kardashian index: K-index = # of followers on Twitter/expected # of followers based on citations. ⭐️Only 1 program director (PD) had K-index>5, an "academic Kardashian" ⭐️Only 11 PDs on Twitter had >100 followers https://t.co/uH408ri5nY @Rheumnow https://t.co/d8VeyzAIcU

Links:

Eric Dein ericdeinmd ( View Tweet)
They are the up and coming leaders in our field! I got to interview them about 👉🏼why #GeriRheum is important (our pts are aging) 👉🏼small changes to your practice for big outcomes 👉🏼Tips: pain control/funx #acr21 @UnaMakris @RheumNow https://t.co/f71L0P3foE via @YouTube

Links:

TheDaoIndex KDAO2011 ( View Tweet)

Great conversation with @BayviewMedicine @jhrheumatology alum Dr. Jason Liebowitz and Professor Janet Zeide on "Gift of Gab"- communications skills for the rheumatologist at #ACR21! @Rheumnow https://t.co/O1u3X8urag

Eric Dein ericdeinmd ( View Tweet)

Watch my interview w/incredible rheum leaders in the field of aging: 👉🏼what inspired them 👉🏼changes we need to make in our practice 👉🏼end of life care (including MD-assisted suicide). #BetterThanNPR #ACR21 @RheumNow @UnaMakris https://t.co/RBfvgHEkpm via @YouTube

Links:

TheDaoIndex KDAO2011 ( View Tweet)

Watch back our recap of the best from Day 2 of #ACR21 in the @RheumNow daily panel. With @AurelieRheumo @RheumNow @Yuz6Yusof @bella_mehta @_Castillo_Pedro https://t.co/ORTbV61c2C

Richard Conway RichardPAConway ( View Tweet)

Dr. Fujimoto provides a wonderful overview of skin findings in DM by antibody #ACR21 #ACRAmbassador https://t.co/KpOsgKPU7j
Veena Katikineni VeenaRheumMD ( View Tweet)
#ACR21 Ab#1166. How many of your pts use marijuana? ⭐️Probably more than you think! ▶️57% have tried, >50% use at least weekly ▶️67% doctors thought <20% of pts use it 🔥Pts over 40 yo MORE likely to report marijuana use @Rheumnow https://t.co/0uW8rZvf1k https://t.co/ShMnR0faHr

Links:

Eric Dein ericdeinmd ( View Tweet)
I will be at the Early Career community Hub in 5 minutes (at 5pm Eastern) with @DanielHSolomon discussing "How to Get Published" #ACR21

Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×